XBiotech Inc. (XBIT): EPS (Diluted)
-$1.49
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$1.49 | n/m | 2026-03-13, From 2025-01-01 |
| 2024-12-31 | -$1.26 | n/m | 2026-03-13, From 2024-01-01 |
| 2023-12-31 | -$0.81 | n/m | 2025-03-18, From 2023-01-01 |
| 2022-12-31 | -$1.08 | n/m | 2024-03-15, From 2022-01-01 |
| 2021-12-31 | -$0.58 | n/m | 2023-03-15, From 2021-01-01 |
| 2020-12-31 | -$0.36 | n/m | 2022-03-15, From 2020-01-01 |
| 2019-12-31 | $14.44 | n/m | 2022-03-15, From 2019-01-01 |
| 2018-12-31 | -$0.59 | n/m | 2021-03-16, From 2018-01-01 |
| 2017-12-31 | -$0.95 | n/a | 2020-03-16, From 2017-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| XBiotech Inc. (XBIT) | 2025-12-31 | -$1.49 | n/m |
| Whitehawk Therapeutics, Inc. (WHWK) | 2025-12-31 | -$0.33 | n/m |
| Veradermics, Inc (MANE) | 2025-12-31 | -$111.91 | n/m |
| Larimar Therapeutics, Inc. (LRMR) | 2024-12-31 | -$1.32 | n/m |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | -$4.19 | n/m |
| Precigen, Inc. (PGEN) | 2025-12-31 | -$1.37 | n/m |
| Boundless Bio, Inc. (BOLD) | 2025-12-31 | -$2.60 | n/m |
| Prelude Therapeutics Inc (PRLD) | 2025-12-31 | -$1.29 | n/m |
| Aquestive Therapeutics, Inc. (AQST) | 2025-12-31 | -$0.78 | n/m |
Compare XBIT, WHWK, MANE, LRMR side by side · Screen every company in Pharmaceutical Preparations ↗